FIP1L1 presence in FIP1L1-RARA or FIP1L1-PDGFRA differentially contributes to the pathogenesis of distinct types of leukemia

FIP1L1 presence in FIP1L1-RARA or FIP1L1-PDGFRA differentially contributes to the pathogenesis of distinct types of leukemia
复制标题

DOI:
10.1007/s00277-014-2085-1
复制
发表时间:
2014-09-01
影响因子:
3.5
通讯作者:
Teshima, Takanori
Teshima, Takanori
中科院分区:
医学3区
文献类型:
--
作者:
Iwasaki, Junko;Kondo, Takeshi;Teshima, Takanori

文献摘要

被引文献

相似文献

FIP 1样1(FIP 1 L1)与两种致白血病融合基因相关:FIP 1 L1-视黄酸受体α(RARA)和FIP 1 L1-血小板衍生生长因子受体α(PDGFRA)。对一系列缺失突变体的分析表明,FIP 1 L1-RARA中的FIP 1基序在其同源二聚化和转录抑制活性中起着关键作用。然而,在FIP 1 L1-PDGFRA中,C-末端PDGFRA部分具有自身形成同源二聚体的能力,使得FIP 1 L1能够组成性激活该激酶。FIP 1 L1-PDGFRA的全长和C-末端PDGFRA部分均可转化IL-3依赖性造血细胞系BAF-B 03。此外,当FIP 1 L1-PDGFRA的全长或C-末端PDGFRA部分被引入这些细胞中时,它们在不存在IL-3的情况下生长。然而,具有FIP 1 L1-PDGFRA的C-末端PDGFRA部分的细胞是部分IL-3依赖性的,而具有全长FIP 1 L1-PDGFRA的细胞的生长变得完全不依赖于IL-3。总之,这些结果表明,FIP 1 L1差异有助于不同类型的白血病的发病机制。
FIP1-like 1 (FIP1L1) is associated with two leukemogenic fusion genes: FIP1L1-retinoic acid receptor alpha (RARA) and FIP1L1-platelet-derived growth factor receptor alpha (PDGFRA). Analyses of a series of deletion mutants revealed that the FIP1 motif in FIP1L1-RARA plays a pivotal role in its homodimerization and transcriptional repressor activity. However, in FIP1L1-PDGFRA, the C-terminal PDGFRA portion possesses the ability of forming a homodimer by itself, making FIP1L1 dispensable for constitutive activation of this kinase. Both the full-length and the C-terminal PDGFRA portion of FIP1L1-PDGFRA could transform the IL-3-dependent hematopoietic cell line, BAF-B03. Moreover, when either the full-length or the C-terminal PDGFRA portion of FIP1L1-PDGFRA was introduced in these cells, they grew in the absence of IL-3. The cells having the C-terminal PDGFRA portion of FIP1L1-PDGFRA, however, were partially IL-3 dependent, whereas the cells having the full-length FIP1L1-PDGFRA became completely IL-3 independent for their growth. Taken together, these results show that FIP1L1 differentially contributes to the pathogenesis of distinct types of leukemia.